GlassScriptPhysician profile
Vonda Klein
NPI 1487629655
$1,698.57
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $164 · 2021: $89.04 · 2022: $350 · 2023: $466 · 2024: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.49 | 2019-2023 | |
| Astellas Pharma US INC | $216.94 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $119.89 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $91.52 | 2022-2023 | |
| Organon LLC | $88.34 | 2022-2024 | Nexplanon, Nuvaring |
| Dysis Medical, INC. | $88.30 | 2023 | Dysis View, Dysis Ultra 2.0, Dysis V3 Digital Coploscope |
| Agile Therapeutics, INC. | $74.30 | 2022-2024 | Twirla |
| Exeltis, USA INC. | $70.56 | 2020-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $69.65 | 2019-2024 | |
| Coopersurgical, INC. | $56.67 | 2019-2021 | |
| Therapeuticsmd, INC. | $54.45 | 2019 | |
| Daiichi Sankyo INC. | $51.70 | 2019-2022 | |
| Duchesnay USA Incorporated | $49.37 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $48.48 | 2022-2023 | Caldolor |
| Merck Sharp & Dohme LLC | $40.98 | 2019-2023 | Gardasil 9 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $36.21 | 2019-2023 | Pico 14, Acticoat 4" X 4", Pico 7 |
| Evofem Biosciences, INC. | $29.20 | 2022-2023 | Phexxi |
| Hologic Sales and Service, LLC | $26.86 | 2019-2023 | Acessa Provu System |
| Allergan, INC. | $26.29 | 2019-2020 | |
| Myovant Sciences INC. | $26.27 | 2022 | |
| Meditrina | $24.51 | 2023 | |
| Avion Pharmaceuticals | $23.02 | 2019-2020 | |
| Shield Therapeutics INC | $22.17 | 2024 | |
| Scynexis, INC. | $18.68 | 2022 | |
| Olympus America INC. | $16.82 | 2022 | |
| Ethicon US, LLC | $15.14 | 2020 | |
| Amag Pharmaceuticals, INC. | $15.07 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.77 | 2019 | |
| Millicent US INC | $14.31 | 2020 | |
| Kci USA, INC. | $14.04 | 2023 | Prevena |
| Aspira Women'S Health INC | $13.57 | 2021 | |
| Minerva Surgical, INC | $13.43 | 2022 | |
| Channel Medsystems, INC. | $8.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vonda Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.